Back to Journals » OncoTargets and Therapy » Volume 11

Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
7,583 Dovepress* 4,366 605+ 601 4,971
PubMed Central* 0 2,612 445 2,612
Totals 4,366 3,217 1,046 7,583
*Since 14 December 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar